Montelukast Sodium Market Expected to Reach New Heights by 2033 Amid Growing Demand for Asthma Treatments

The global Montelukast Sodium Market is expected to experience rapid growth from 2026 to 2033, according to a recent study published by Coherent Market Insights. The market size is projected to increase due to the growing demand for asthma management and allergic rhinitis treatments.

The report highlights key players in the industry, including Merck & Co. Inc., Teva Pharmaceutical Industries Ltd., and Mylan N.V. These companies are expected to dominate the market share, with Merck & Co. Inc. being a leading player due to its strong product portfolio and extensive distribution network.

The Montelukast Sodium Market is segmented by type and application, with pediatric patients, adult patients, asthma management, allergic rhinitis, chronic obstructive pulmonary disease (COPD), combination therapy, hospital pharmacies, and retail pharmacies being the major segments. The report provides detailed analysis of each segment, including revenue forecasts and growth trends.

The study also examines the competitive landscape, highlighting key drivers and restraints influencing market expansion. It is expected that emerging trends in personalized medicine and precision healthcare will contribute to the growth of the Montelukast Sodium Market.